Medeor Therapeutics, Inc.
Records under this name other than the patents Medeor Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 2 of 2 · Back to Medeor Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,435,350 | Methods of Analysis of Blood from Deceased Donors Lapsed on the fee record Ended Sep 6, 2026 · High confidence | Lapsed on the fee record | Ended Sep 6, 2026 | High confidence |
| US 11,273,179 | Methods for treating non-cancerous disorders using hematopoietic cells Lapsed on the fee record Ended Mar 15, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2026 | USPTO record |